Japan Medical Dynamic Marketing, Inc.(JP:7600)
Â¥318.0013.00 (-14.52%)
JP:7600
Japan Medical Dynamic Marketing, Inc. financials statements
Â¥318.00
At close:13.00 (-14.52%)
Want to see JP:7600 full AI Analyst Report?
Japan Medical Dynamic Marketing, Inc. (7600) Ratios
0 Followers
Japan Medical Dynamic Marketing, Inc. Ratios
JP:7600's free cash flow for Q1 2026 was ¥0.00. For the 2026 fiscal year, JP:7600's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.23 | 3.29 | 5.35 | 5.51 | 6.22 |
| Quick Ratio | 1.13 | 1.37 | 2.11 | 2.31 | 2.74 |
| Cash Ratio | 0.40 | 0.44 | 0.58 | 0.77 | 0.89 |
| Solvency Ratio | 0.18 | 0.13 | 0.49 | 0.48 | 0.61 |
| Operating Cash Flow Ratio | 0.03 | 0.14 | 0.52 | 0.60 | 1.07 |
| Short-Term Operating Cash Flow Coverage | 0.04 | 0.33 | 1.81 | 2.09 | 5.59 |
| Net Current Asset Value | ¥ 14.64B | ¥ 14.78B | ¥ 15.70B | ¥ 13.83B | ¥ 12.20B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.16 | 0.10 | 0.05 | 0.06 | 0.07 |
| Debt-to-Equity Ratio | 0.23 | 0.13 | 0.06 | 0.08 | 0.09 |
| Debt-to-Capital Ratio | 0.19 | 0.12 | 0.06 | 0.07 | 0.08 |
| Long-Term Debt-to-Capital Ratio | 0.03 | 0.00 | 0.01 | 0.03 | 0.06 |
| Financial Leverage Ratio | 1.40 | 1.37 | 1.23 | 1.27 | 1.28 |
| Debt Service Coverage Ratio | 0.38 | 0.40 | 2.46 | 2.83 | 6.13 |
| Interest Coverage Ratio | 2.86 | 20.65 | 54.97 | 111.58 | 89.61 |
| Debt to Market Cap | 0.40 | 0.22 | 0.07 | 0.06 | 0.04 |
| Interest Debt Per Share | 230.45 | 127.66 | 57.98 | 71.72 | 71.20 |
| Net Debt to EBITDA | 1.26 | 0.07 | -0.25 | -0.28 | -0.18 |
| Profitability Margins | |||||
| Gross Profit Margin | 53.27% | 62.30% | 63.69% | 65.67% | 67.67% |
| EBIT Margin | 2.40% | -1.06% | 7.20% | 8.39% | 14.48% |
| EBITDA Margin | 9.15% | 5.59% | 14.12% | 15.71% | 21.92% |
| Operating Profit Margin | 2.40% | 6.20% | 7.54% | 9.50% | 13.87% |
| Pretax Profit Margin | 2.06% | -1.36% | 7.06% | 8.31% | 14.33% |
| Net Profit Margin | 1.10% | -1.84% | 5.49% | 6.68% | 11.13% |
| Continuous Operations Profit Margin | 1.15% | -1.87% | 5.63% | 6.74% | 11.16% |
| Net Income Per EBT | 53.31% | 134.87% | 77.69% | 80.45% | 77.67% |
| EBT Per EBIT | 85.97% | -22.01% | 93.70% | 87.41% | 103.32% |
| Return on Assets (ROA) | 0.74% | -1.37% | 4.04% | 4.84% | 7.81% |
| Return on Equity (ROE) | 1.04% | -1.87% | 4.98% | 6.15% | 9.99% |
| Return on Capital Employed (ROCE) | 2.05% | 5.86% | 6.36% | 7.85% | 10.89% |
| Return on Invested Capital (ROIC) | 0.97% | 5.23% | 4.86% | 6.11% | 8.28% |
| Return on Tangible Assets | 0.75% | -1.38% | 4.07% | 4.88% | 7.90% |
| Earnings Yield | 1.86% | -3.08% | 6.60% | 5.19% | 4.94% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.57 | 4.10 | 3.92 | 4.04 | 3.68 |
| Payables Turnover | 8.00 | 7.11 | 6.00 | 7.47 | 7.90 |
| Inventory Turnover | 0.69 | 0.68 | 0.64 | 0.63 | 0.61 |
| Fixed Asset Turnover | 2.72 | 3.16 | 2.79 | 2.75 | 2.47 |
| Asset Turnover | 0.67 | 0.74 | 0.74 | 0.72 | 0.70 |
| Working Capital Turnover Ratio | 1.42 | 1.47 | 1.37 | 1.35 | 1.34 |
| Cash Conversion Cycle | 562.55 | 573.09 | 600.08 | 620.46 | 646.80 |
| Days of Sales Outstanding | 79.91 | 89.01 | 93.09 | 90.27 | 99.10 |
| Days of Inventory Outstanding | 528.25 | 535.39 | 567.85 | 579.05 | 593.92 |
| Days of Payables Outstanding | 45.60 | 51.31 | 60.86 | 48.86 | 46.22 |
| Operating Cycle | 608.16 | 624.40 | 660.94 | 669.32 | 693.02 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 7.80 | 39.74 | 79.97 | 82.96 | 117.94 |
| Free Cash Flow Per Share | -66.61 | -19.14 | 11.49 | 33.04 | 57.86 |
| Dividend Paid and CapEx Coverage Ratio | 0.09 | 0.54 | 0.98 | 1.34 | 1.66 |
| Capital Expenditure Coverage Ratio | 0.10 | 0.67 | 1.17 | 1.66 | 1.96 |
| Operating Cash Flow Coverage Ratio | 0.04 | 0.32 | 1.41 | 1.17 | 1.68 |
| Operating Cash Flow to Sales Ratio | 0.01 | 0.04 | 0.09 | 0.10 | 0.16 |
| Free Cash Flow Yield | -12.40% | -3.36% | 1.57% | 3.17% | 3.53% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 53.75 | -32.50 | 15.15 | 19.27 | 20.24 |
| Price-to-Sales (P/S) Ratio | 0.59 | 0.60 | 0.83 | 1.29 | 2.25 |
| Price-to-Book (P/B) Ratio | 0.56 | 0.61 | 0.76 | 1.18 | 2.02 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -8.06 | -29.78 | 63.71 | 31.51 | 28.31 |
| Price-to-Operating Cash Flow Ratio | 68.83 | 14.34 | 9.15 | 12.55 | 13.89 |
| Price-to-Earnings Growth (PEG) Ratio | -0.34 | 0.24 | -1.43 | -0.58 | 0.71 |
| Enterprise Value Multiple | 7.73 | 10.76 | 5.63 | 7.92 | 10.09 |
| Enterprise Value | 16.91B | 15.11B | 18.44B | 26.50B | 42.47B |
| EV to EBITDA | 7.73 | 10.76 | 5.63 | 7.92 | 10.09 |
| EV to Sales | 0.71 | 0.60 | 0.80 | 1.24 | 2.21 |
| EV to Free Cash Flow | -9.64 | -29.98 | 60.97 | 30.44 | 27.82 |
| EV to Operating Cash Flow | 82.27 | 14.44 | 8.76 | 12.12 | 13.65 |
| Tangible Book Value Per Share | 948.80 | 923.17 | 964.37 | 873.91 | 803.49 |
| Shareholders’ Equity Per Share | 964.07 | 937.15 | 969.19 | 878.94 | 810.59 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.44 | -0.37 | 0.20 | 0.19 | 0.22 |
| Revenue Per Share | 907.78 | 953.66 | 880.53 | 808.60 | 727.46 |
| Net Income Per Share | 9.99 | -17.54 | 48.31 | 54.03 | 80.95 |
| Tax Burden | 0.53 | 1.35 | 0.78 | 0.80 | 0.78 |
| Interest Burden | 0.86 | 1.28 | 0.98 | 0.99 | 0.99 |
| Research & Development to Revenue | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 |
| SG&A to Revenue | 0.47 | 0.46 | 0.18 | 0.17 | 0.15 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.78 | -2.27 | 1.29 | 1.24 | 1.13 |
Currency in JPY
